Low serum levels of prohepcidin, but not hepcidin-25, are related to anemia in familial amyloidosis TTR V30M

Blood Cells, Molecules, and Diseases

Volumn 41, Issue 2, 2008, Pages 175-178

  Beirão, Idalina ^a,b,c   Almeida, Susana ^d   Swinkels, Dorine ^e   Costa, Paulo M P ^b,c   Moreira, Luciana ^b   Fonseca, Isabel ^a,b   Freitas, Cristina ^a   Cabrita, António ^a   Porto, Graça ^a,c,d  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^b NATIONAL INSTITUTE OF HEALTH   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anemia; Familial amyloidosis TTR V30M; Hepcidin; Interleukin 6; Prohepcidin

Indexed keywords

C REACTIVE PROTEIN; ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; HEPCIDIN; HEPCIDIN 25; INTERLEUKIN 6; PROHEPCIDIN; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ADULT; AGED; ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL AMYLOIDOSIS; FEMALE; FERRITIN BLOOD LEVEL; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; TRANSFERRIN BLOOD LEVEL;

AMYLOIDOSIS, FAMILIAL; ANEMIA; ANTIMICROBIAL CATIONIC PEPTIDES; CASE-CONTROL STUDIES; ERYTHROPOIETIN; HEMATOLOGIC TESTS; HUMANS; INFLAMMATION; PORTUGAL; PROTEIN PRECURSORS;

EID: 48749088914     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2008.04.008     Document Type: Article

References (20)

1. Saraiva M.J., Birken S., Costa P.P., and Goodman D.S. Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). J. Clin. Invest. 74 (1984) 104-119
2. Lobato L. Portuguese-type amyloidosis (transthyretin amyloidosis, ATTR V30M). J. Nephrol. 16 (2003) 438-442
3. Olofsson B.O., Grankvist K., and Boman K. Evaluation of the anemia in familial amyloidotic polyneuropahy. Eur. J. Int. Med. (1990) 1425-1429
4. Beirão I., Lobato L., Costa P.M., Fonseca I., Mendes P., Silva M., Bravo F., Cabrita A., and Porto G. Kidney and anemia in familial amyloidosis type I. Kidney Int. 66 (2004) 2004-2009
5. Beutler E., and Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration?. Blood 107 (2006) 1747-1750
6. Jelkmann W. Proinflammatory cytokines lowering erythropoietin production. J. Interferon Cytokine Res. 18 (1998) 555-559
7. Andrews N.C. Anemia of inflammation: the cytokine-hepcidin link. J. Clin. Invest. 113 (2004) 1251-1253
8. Nemeth E., Rivera S., Gabayan V., Keller C., Taudorf S., Pedersen B.K., and Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 113 (2004) 1271-1276
9. Kemna E.H., Tjalsma H., Willems H.L., and Swinkels D.W. Hepcidin: from discovery to differential diagnosis. Haematologica 93 (2008) 90-97
10. Luukkonen S., and Punnonen K. Serum pro-hepcidin concentrations and their responses to oral iron supplementation in healthy subjects manifest considerable inter-individual variation. Clin. Chem. Lab. Med. 44 (2006) 1361-1362
11. Hadley K.B., Johnson L.K., and Hunt J.R. Iron absorption by healthy women is not associated with either serum or urinary prohepcidin. Am. J. Clin. Nutr. 84 (2006) 150-155
12. Roe M.A., Spinks C., Heath A.L., Harvey L.J., Foxall R., Wimperis J., Wolf C., and Fairweather-Tait S.J. Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary hemochromatosis patients undergoing phlebotomy treatment, or pregnant women. Br. J. Nutr. 97 (2007) 544-549
13. Kemna E., Pickkers P., Nemeth E., van der Hoeven H., and Swinkels D. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 106 (2005) 1864-1866
14. Kemna E.H., Kartikasari A.E., van Tits L.J., Pickkers P., Tjalsma H., and Swinkels D.W. Regulation of hepcidin: insights from biochemical analyses on human serum samples. Blood Cells Mol. Diseases 40 (2008) 339-346
15. Zoller H., McFarlane I., Theurl I., Stadlmann S., Nemeth E., Oxley D., Ganz T., Halsall D.J., Cox T.M., and Vogel W. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease. Hepatology 42 (2005) 466-472
16. Truksa J., Peng H., Lee P., and Beutler E. Different regulatory elements are required for response of hepcidin to interleukin-6 and bone morphogenetic proteins 4 and 9. Br. J. Haematol. 139 (2007) 138-147
17. Valore E.V., and Ganz T. Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin. Blood Cells Mol. Dis. 40 (2008) 132-138
18. Lee P. Commentary to: "Post-translational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin," by Erika Valore and Tomas Ganz. Blood Cells Mol. Dis. 40 (2008) 139-140
19. Kulaksiz H., Theilig F., Bachmann S., Gehrke S.G., Rost D., Janetzko A., Cetin Y., and Stremmel W. The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J. Endocrinol. 184 (2005) 361-370
20. Pinto J.P., Ribeiro S., Pontes H., Thowfeequ S., Tosh D., Carvalho F., and Porto G. Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signalling and regulation of C/EBPalpha. Blood (2008) [Electronic publication ahead of print]